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SIMULTANEOUS pancreas-kidney transplantation(SPKT) is, at present, the best treatment for patients
with type 1 diabetes with chronic renal failure. Several
studies have proved that SPKT significantly improves the
quality of life,1 neuropathy, 2 cardiopathy,3 and may prevent
recurrent nephropathy in the kidney graft.4 Since the
introduction of new immunosuppressive drugs, there has
been a marked outcome improvement in SPKT. Its popu-
larity parallels these improving results, such that SPKT is
now a world-wide practice.5 We present herein the results
of the first 12 cases of our program.
METHODS
We started our program on May 2, 2000, performing our 12th
SPKT on April 20, 2002. SPKT uses the whole pancreas, with
enteric diversion of the exocrine secretions, and the iliac vessels for
vascular supply and drainage. The immunosuppressive protocol
includes quadruple-drug therapy, namely, anti-thymocyte globulin,
tacrolimus, mycophenolate mofetil, and steroids. Infection prophy-
laxis during the first 3 days includes a third-generation cephalospo-
rin, vancomycin, and fluconazol followed by gancyclovir and cotri-
moxazol; for thrombosis prophylaxis, we begin acetyl salycilic acid
and low–molecular weight heparin preoperatively.
RESULTS
The mean age of the patients was 32.0  6.2 years and the
mean duration of diabetes was 21.1  2.8 years. Nine
patients received an organ displaying at least one HLA
match. One patient was on the “urgent” waiting list due to
lack of vascular access for hemodialysis. During the pre-
transplantation evaluation one patient required coronary
angioplasty after a myocardial infarction. The total length
of hospital stay was 36.7  21.9 days (range: 10 to 82 days),
including 6.4  13.1 days (range: 1 to 48 days) in the
intensive care unit. Only one patient needed dialysis for 13
days after SPKT due to shock. Exogenous insulin was
stopped 2.1  1.8 days after SPKT. Four patients required
two to four surgical reinterventions due to abdominal
infection or bleeding. Nine patients’ courses were compli-
cated by extraurinary infections, namely, perigraft infec-
tions and six with urinary infections. The incidence of acute
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Table 1. Latest Analytical Values of Graft Function and Metabolic Control
Patient
No.
Urea
(mg/dL)
Creatinine
(mg/dL)
Glucose
(mg/dL)
HbA1c
(%)
C-peptide
(ng/mL)
Cholesterol
(mg/dL)
Triglycerides
(mg/dL)
1 52 0.8 80 4.8 6.9 221 127
2 62 1.3 61 4.0 6.1 172 97
3 42 0.9 78 4.3 7.7 214 81
4 60 0.9 97 5.5 3.9 220 169
5 50 1.3 94 5.0 7.3 152 116
6 60 1.1 71 4.9 5.6 151 51
7 32 0.8 68 5.2 6.4 167 184
8 24 0.7 88 4.9 7.1 156 127
9 36 0.9 63 4.6 6.1 164 105
10 53 1.0 72 4.4 7.9 133 86
11 66 1.4 92 5.1 6.3 183 139
12 47 1.1 84 5.0 8.3 155 177
Mean (SD) 48.5  12.9 1.0  0.2 72.7  16.4 4.7  0.8 6.8  1.5 167  31 138  45
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rejection episodes (AR) was 50% (six patients with AR: one
of kidney, three of the pancreas, and two of both organs).
The diagnosis was based on clinical criteria including serum
urea, creatinine, amylase, and lipase as well as kidney
biopsy. In one third of the cases it was steroid-resistant but
only one patient had more than one AR episode. Five of the
12 patients were readmitted, due to infection, AR, periph-
eral vascular disease, or ocular problems. They had one to
four admissions. Until now all the patients have both grafts
functioning without an exogenous insulin requirement. At
last visit, the mean values were 48.5  12.9 and 1.0  0.2
mg/dL for blood urea and creatinine, respectively; 72.7 
16.4 mg/dL for fasting blood sugar; 4.7  0.8% for HbA1c;
6.8  1.5 ng/mL for C-peptide; 167  31 and 138  45
mg/dL for cholesterol and triglycerides, respectively (Table
1).
DISCUSSION AND CONCLUSIONS
It is possible that our incidence of AR is an overestimate,
especially pancreas rejection, because it was inferred from
the biochemical level of pancreatic enzymes and from the
kidney biopsy. However, our center decided not to perform
pancreatic graft biopsies, at least in the beginning of the
program, to avoid additional risks associated with the
technique. Although there are some aspects that can cer-
tainly be improved, such as surgery related complications,
bleeding, and infection, SPKT has been a successful expe-
rience at our center. All patients are alive and all grafts
functioning. This outcome proffers a strong motivation to
continue the program.
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